LED Light Therapy (Photobiomodulation): How It Works, Benefits and Clinical Applications

What Is Photobiomodulation?

Photobiomodulation (PBM) — commonly referred to as LED light therapy in clinical and aesthetic settings — is the application of low-level, non-ionising light energy at specific wavelengths to biological tissue. Unlike lasers, which use high-intensity, coherent light to ablate or thermally damage tissue, LED devices deliver low-level light energy that is absorbed by cellular chromophores without generating destructive heat.

The term "photobiomodulation" was formalised by the World Association for Laser Therapy (WALT) to replace older terms such as "low-level laser therapy" (LLLT) and "cold laser therapy," as LED sources became dominant in clinical practice. The underlying science is the same: specific wavelengths of light activate mitochondrial photoreceptors — primarily cytochrome c oxidase — triggering a cascade of intracellular signalling events that ultimately promote tissue repair, reduce inflammation, and modulate cellular behaviour.

The Science: How Light Affects Skin Cells

The mechanism of photobiomodulation centres on the mitochondria — the cellular organelles responsible for energy production. When photons at the appropriate wavelength are absorbed by cytochrome c oxidase (the terminal enzyme in the mitochondrial electron transport chain), the following sequence of events occurs:

1. Increased ATP synthesis: Light absorption enhances mitochondrial respiration and elevates cellular energy availability (adenosine triphosphate, ATP).
2. Release of nitric oxide (NO): Nitric oxide — which normally inhibits cytochrome c oxidase — is dissociated by light energy, improving cellular oxygen metabolism and promoting vasodilation.
3. Reactive oxygen species (ROS) signalling: Controlled, sub-toxic levels of ROS act as secondary messengers that activate transcription factors including NF-κB and AP-1, modulating gene expression.
4. Downstream cellular effects: Increased fibroblast proliferation and collagen synthesis, enhanced keratinocyte migration, reduced pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), and modulation of growth factor expression (TGF-β, bFGF, VEGF).

This photochemical cascade — not a thermal or mechanical effect — distinguishes photobiomodulation from all other energy-based skin treatments.

Key Wavelengths and Their Clinical Applications

Different wavelengths of light penetrate to different depths in the skin and interact with different chromophores and cellular targets. In clinical LED therapy, the most evidence-supported wavelengths are:

Blue Light (415–470 nm)

• Primary target: Porphyrins produced by Cutibacterium acnes (formerly Propionibacterium acnes).
• Mechanism: Blue light is absorbed by endogenous porphyrins within acne bacteria, generating cytotoxic singlet oxygen that destroys the bacteria — a process known as photodynamic inactivation.
• Penetration depth: Superficial (epidermis and upper dermis); does not penetrate deep enough to reach subcutaneous tissue.
• Clinical evidence: Multiple randomised controlled trials confirm reductions in inflammatory acne lesion counts of 55–76% after 8–12 weeks of treatment. Most effective for mild to moderate inflammatory acne; less effective for comedonal or nodulocystic disease.
• Additional effects: Anti-inflammatory action on sebaceous glands; may modestly reduce sebum production.

Red Light (620–700 nm; clinical optimum ~630–660 nm)

• Primary targets: Fibroblasts, keratinocytes, mitochondria in the mid-to-deep dermis.
• Mechanism: Stimulates fibroblast proliferation and type I and III collagen synthesis; reduces matrix metalloproteinases (MMPs) that break down existing collagen; enhances wound healing; anti-inflammatory.
• Penetration depth: Reaches mid-dermis (approximately 2–3 mm); deeper than blue light.
• Clinical evidence: Well-supported for photoaged skin, fine line reduction, improved skin texture and elasticity, post-procedure wound healing (after laser, needling, peels), and rosacea management.
• Combination use: The most commonly used wavelength in combination LED panels; synergises well with near-infrared for deeper tissue effects.

Near-Infrared Light (800–1000 nm; clinical optimum ~830–850 nm)

• Primary targets: Deep dermis, subcutaneous tissue, nerve endings, blood and lymphatic vessels.
• Mechanism: Deepest tissue penetration (up to 5–10 mm); powerful anti-inflammatory effects; accelerates tissue repair; reduces oedema via improved lymphatic drainage; analgesic effect through modulation of pain signalling.
• Penetration depth: Deepest of the three primary LED wavelengths.
• Clinical applications: Post-procedural recovery acceleration, reduction of post-treatment bruising and oedema, chronic inflammatory skin conditions, wound healing support, musculoskeletal pain adjacent to skin (when used in combination with physiotherapy).

Yellow and Green Light (520–590 nm)

• Yellow light (590 nm) is used for its effects on superficial vascular lesions, post-inflammatory erythema, and improving skin radiance.
• Green light (520–550 nm) targets melanocytes and has been investigated for hyperpigmentation and melasma, though evidence is less robust than for red and blue wavelengths.

Clinical Indications for LED Light Therapy

Acne Vulgaris

Blue light (415 nm) alone or in combination with red light is a well-validated, antibiotic-free treatment option for mild to moderate inflammatory acne. The blue/red combination addresses both the bacterial and inflammatory components of acne, delivering superior results to blue light monotherapy. A typical protocol involves 8–12 sessions of 15–20 minutes, 2–3 times per week. LED therapy can be used alongside topical acne regimens or as a standalone treatment for patients unable to tolerate conventional topical or oral agents.

Skin Ageing and Photoageing

Red and near-infrared LED therapy stimulates neocollagenesis and improves skin texture, tone and elasticity in photoaged skin. Clinical studies have demonstrated statistically significant improvements in fine lines, skin roughness, and dermal density after 8–15 sessions. While the magnitude of individual improvements is more modest than ablative laser resurfacing, LED therapy provides meaningful improvement with zero downtime and no restriction on subsequent UV exposure.

Post-Procedure Recovery

One of the most widely used applications of LED therapy in clinical aesthetics is post-procedure recovery enhancement. Performed immediately or within 24 hours after microneedling, fractional laser resurfacing, chemical peels, or thread lifts, a red/near-infrared LED session can:

• Reduce procedural erythema and oedema more rapidly
• Shorten the visible downtime period
• Accelerate epidermal repair
• Enhance the collagen response triggered by the primary procedure
• Reduce the risk of post-inflammatory hyperpigmentation

Rosacea

Red and near-infrared wavelengths reduce chronic inflammation in rosacea-prone skin. Multiple sessions can decrease persistent erythema, reduce flushing episodes, and improve overall skin comfort. LED therapy does not eliminate vascular lesions (for which vascular lasers are preferred) but significantly reduces the inflammatory component of rosacea.

Wound Healing and Scar Prevention

Photobiomodulation accelerates wound healing by stimulating fibroblast activity, enhancing growth factor expression, and reducing chronic inflammation. It has been used clinically to support healing of post-surgical wounds, ulcers, and hypertrophic scars. Early application (within the first weeks of scar formation) may influence scar remodelling favourably.

Hair Loss (Androgenetic Alopecia)

Low-level red/near-infrared light therapy for the scalp — delivered via LED panels or laser caps — has FDA-cleared status in the United States for androgenetic alopecia in both men and women. The mechanism involves stimulation of anagen phase hair follicle activity, increased blood flow to the follicular unit, and anti-inflammatory effects on the scalp microenvironment. Results require 4–6 months of consistent use and are primarily maintenance- and density-focused rather than fully restorative.

LED Therapy Protocols: What to Expect

In-Clinic Session

A standard clinical LED therapy session at Virtuana Clinic follows this sequence:

1. Skin preparation: The skin is thoroughly cleansed to remove makeup, SPF, and any topical products that might absorb or scatter the light.
2. Eye protection: Opaque goggles are applied to protect the eyes from light exposure.
3. LED panel placement: A medical-grade LED panel (or mask) is positioned approximately 1–5 cm from the skin surface, depending on the device and protocol.
4. Treatment duration: Sessions typically last 15–30 minutes. Specific duration, wavelength, and energy dosage are determined by the treatment indication.
5. Post-treatment: No special aftercare is required. Sunscreen application and standard skincare can be resumed immediately.

Typical Session Frequency

Indication	Induction Course	Maintenance
Acne (mild–moderate)	8–12 sessions, 2–3×/week	1–2×/week or as needed
Anti-ageing / skin quality	10–15 sessions, 2×/week	Monthly
Post-procedure recovery	1–3 sessions in first week post-procedure	Per procedure schedule
Rosacea	8–10 sessions, 2×/week	Every 4–6 weeks
Scalp (hair loss)	12–16 sessions, 2–3×/week	Weekly–biweekly

Who Is a Suitable Candidate?

LED photobiomodulation is suitable for a very wide patient population. It is appropriate for:

• All Fitzpatrick skin types (I–VI) — no risk of thermal damage or hyperpigmentation
• Patients with active mild to moderate inflammatory acne
• Those seeking non-invasive anti-ageing support without downtime
• Post-procedure patients looking to accelerate healing
• Patients with rosacea, chronic facial redness, or sensitive reactive skin
• Those with androgenetic hair thinning seeking a complement to other hair restoration approaches

Contraindications

LED therapy is contraindicated or requires specialist assessment in the following situations:

• Active photosensitive conditions: lupus erythematosus, porphyria, xeroderma pigmentosum
• Current use of photosensitising medications (see the article on drug-induced skin reactions for a list)
• Active herpes labialis or herpetic eruption at the proposed treatment site (light may trigger reactivation)
• Active epilepsy (flickering light stimulus)
• Pregnancy (precautionary; insufficient data)
• Direct irradiation over malignant or suspected malignant lesions
• Implanted electronic devices (e.g. pacemakers, cochlear implants) in proximity to the treatment area

LED Therapy vs. Other Light-Based Treatments

Feature	LED Therapy	IPL	Fractional Laser
Mechanism	Photochemical (non-thermal)	Photothermal	Photothermal / ablative
Pain	None	Mild–moderate	Moderate–significant
Downtime	None	1–5 days	3–14 days
Skin type risk	None (all types)	Moderate (darker types)	High (ablative, darker types)
Result magnitude	Gradual, cumulative	Moderate–high	High

LED therapy is most appropriately positioned as a complementary or maintenance treatment rather than a standalone replacement for more intensive procedures in cases requiring significant structural correction. However, for patients who are not candidates for more invasive treatments, or who want a zero-downtime option, it represents excellent stand-alone value.

Conclusion

LED photobiomodulation is one of the most scientifically grounded, versatile, and patient-friendly technologies in modern dermatology and aesthetic medicine. Its non-thermal, non-ablative mechanism makes it uniquely safe across all skin types and an ideal partner for other aesthetic treatments. Whether used for acne control, anti-ageing support, rosacea management, or post-procedure recovery, LED therapy delivers meaningful clinical benefits without discomfort or downtime.

At Virtuana Clinic, LED therapy is available as a standalone treatment and as part of combination protocols. Please contact us for a personalised consultation and pricing information tailored to your skin concerns.

References

1. Hamblin MR. "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." AIMS Biophysics. 2017;4(3):337-361. [PubMed]
2. Avci P, Gupta A, Sadasivam M, et al. "Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring." Semin Cutan Med Surg. 2013;32(1):41-52. [PubMed]
3. Gold MH, Andriessen A, Biron J, Andriessen H. "Clinical efficacy of self-applied blue light therapy for mild-to-moderate facial acne." J Clin Aesthet Dermatol. 2009;2(3):44-50. [PubMed]
4. Wunsch A, Matuschka K. "A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase." Photomed Laser Surg. 2014;32(2):93-100. [PubMed]
5. Lanzafame RJ, Blanche RR, Bodian AB, Chiacchierini RP, Fennel A, Hurtado E. "The growth of human scalp hair mediated by visible red light laser and LED sources in males." Lasers Surg Med. 2013;45(8):487-495. [PubMed]
6. Emer J, Waldorf H, Berson D. "Utilizing Combination Laser Therapy with Photodynamic Therapy in the Treatment of Onychomycosis." J Drugs Dermatol. 2011;10(12):1319-1324.

This article is for informational purposes only. Please consult a qualified physician for diagnosis and treatment decisions.